|
Identified Beclin 2 as a critical negative regulator of inflammation and lymphoma development making it and its interacting proteins potential therapeutic targets
Developing novel strategies to modulate Beclin 2 as a method to treat neurodegenerative diseases and cancer which has the potential to be first-in-class
Abstract
USC researchers identified...
|